CTLA4 and neoplasm: Similarly, in mice that have received orthotopic injection of 4T1 mammary tumor cells, the anti-PD1/anti-CTLA4 treatment in combination with CB-1158 significantly reduces growth of the primary tumor and decreases the number of lung metastases (Steggerda et al., 2017).